Expression of Human PTEN-L in a Yeast Heterologous Model Unveils Specific N-Terminal Motifs Controlling PTEN-L Subcellular Localization and Function.


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
26 11 2019
Historique:
received: 31 10 2019
revised: 21 11 2019
accepted: 22 11 2019
entrez: 30 11 2019
pubmed: 30 11 2019
medline: 25 7 2020
Statut: epublish

Résumé

The tumour suppressor PTEN is frequently downregulated, mutated or lost in several types of tumours and congenital disorders including PHTS (PTEN Hamartoma Tumour Syndrome) and ASD (Autism Spectrum Disorder). PTEN is a lipid phosphatase whose activity over the lipid messenger PIP

Identifiants

pubmed: 31779149
pii: cells8121512
doi: 10.3390/cells8121512
pmc: PMC6952770
pii:
doi:

Substances chimiques

PTEN Phosphohydrolase EC 3.1.3.67
PTEN protein, human EC 3.1.3.67

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

PLoS One. 2015 Feb 25;10(2):e114250
pubmed: 25714556
Autophagy. 2018;14(10):1742-1760
pubmed: 29969932
J Biol Chem. 2010 Apr 23;285(17):12620-8
pubmed: 20177066
Cell Res. 2018 Aug;28(8):787-802
pubmed: 29934616
Methods. 2015 May;77-78:172-9
pubmed: 25448481
Mol Biol Rep. 2018 Dec;45(6):2869-2881
pubmed: 30145641
Nat Rev Mol Cell Biol. 2018 Sep;19(9):547-562
pubmed: 29858604
Nat Commun. 2017 Mar 23;8:14771
pubmed: 28332494
Cell. 2014 Apr 24;157(3):595-610
pubmed: 24766807
Sci Signal. 2014 Jul 01;7(332):pe15
pubmed: 24985344
Science. 2019 May 17;364(6441):
pubmed: 31097636
J Clin Invest. 2019 Feb 1;129(2):452-464
pubmed: 30614812
Methods. 2015 May;77-78:3-10
pubmed: 25843297
Cell Signal. 2015 Nov;27(11):2272-84
pubmed: 26261079
Oncogene. 2007 Jun 7;26(27):3930-40
pubmed: 17213812
Cell. 2007 Jan 12;128(1):141-56
pubmed: 17218261
Proc Natl Acad Sci U S A. 2009 Jan 13;106(2):480-5
pubmed: 19114656
Proc Natl Acad Sci U S A. 2014 Jul 1;111(26):E2684-93
pubmed: 24979808
Cell Mol Life Sci. 2017 Aug;74(15):2783-2794
pubmed: 28289760
Am J Hum Genet. 2018 May 3;102(5):943-955
pubmed: 29706350
Proc Natl Acad Sci U S A. 1998 Nov 10;95(23):13513-8
pubmed: 9811831
Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):7491-6
pubmed: 12808147
Structure. 2015 Oct 6;23(10):1952-1957
pubmed: 26299948
Nat Commun. 2017 Nov 15;8(1):1508
pubmed: 29142193
Eur J Hum Genet. 2018 Aug;26(8):1180-1187
pubmed: 29706633
Adv Enzyme Regul. 2009;49(1):190-6
pubmed: 19168090
Biochem J. 2005 Sep 1;390(Pt 2):613-23
pubmed: 15913452
Open Biol. 2016 May;6(5):
pubmed: 27249819
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Cell Death Differ. 2007 Mar;14(3):395-9
pubmed: 17186024
Cancers (Basel). 2019 Aug 26;11(9):null
pubmed: 31454965
Cell. 1999 Oct 29;99(3):323-34
pubmed: 10555148
Molecules. 2018 Jan 30;23(2):null
pubmed: 29385737
Cancer Res. 2007 Oct 15;67(20):9731-9
pubmed: 17942903
Front Oncol. 2015 Feb 16;5:24
pubmed: 25763354
PLoS One. 2015 Jan 21;10(1):e0116898
pubmed: 25607987
Cell Signal. 2012 Feb;24(2):577-87
pubmed: 22036806
Science. 2013 Jul 26;341(6144):399-402
pubmed: 23744781
Biomolecules. 2019 Apr 17;9(4):
pubmed: 30999672
Oncogene. 2017 Jun 29;36(26):3673-3685
pubmed: 28263967
Methods Mol Biol. 2016;1447:1-23
pubmed: 27514797
Proc Natl Acad Sci U S A. 1997 Aug 19;94(17):9052-7
pubmed: 9256433
Cancer Res. 2000 Dec 15;60(24):7033-8
pubmed: 11156408
J Biol Chem. 2003 Sep 5;278(36):33617-20
pubmed: 12857747
Biosci Rep. 2017 Mar 15;37(2):
pubmed: 28143957
Biochem J. 2016 Jan 15;473(2):135-44
pubmed: 26527737
PLoS One. 2015 Apr 15;10(4):e0119287
pubmed: 25875300
Mol Biol Cell. 2006 Sep;17(9):4002-13
pubmed: 16807353
Hum Mol Genet. 2011 Nov 1;20(21):4132-42
pubmed: 21828076
Annu Rev Biochem. 2014;83:641-69
pubmed: 24905788
Cell Metab. 2014 May 6;19(5):836-48
pubmed: 24768297
Arch Biochem Biophys. 2015 Dec 1;587:48-60
pubmed: 26471078

Auteurs

Teresa Fernández-Acero (T)

Departamento de Microbiología y Parasitología, Facultad de Farmacia, Universidad Complutense de Madrid (UCM) & Instituto Ramón y Cajal de Investigaciones Sanitarias (IRYCIS). Plaza de Ramón y Cajal s/n, 28040 Madrid, Spain.

Eleonora Bertalmio (E)

Departamento de Microbiología y Parasitología, Facultad de Farmacia, Universidad Complutense de Madrid (UCM) & Instituto Ramón y Cajal de Investigaciones Sanitarias (IRYCIS). Plaza de Ramón y Cajal s/n, 28040 Madrid, Spain.

Sandra Luna (S)

Instituto de Investigación Sanitaria Biocruces Bizkaia, 48903 Barakaldo, Spain.

Janire Mingo (J)

Instituto de Investigación Sanitaria Biocruces Bizkaia, 48903 Barakaldo, Spain.

Ignacio Bravo-Plaza (I)

Departamento de Microbiología y Parasitología, Facultad de Farmacia, Universidad Complutense de Madrid (UCM) & Instituto Ramón y Cajal de Investigaciones Sanitarias (IRYCIS). Plaza de Ramón y Cajal s/n, 28040 Madrid, Spain.

Isabel Rodríguez-Escudero (I)

Departamento de Microbiología y Parasitología, Facultad de Farmacia, Universidad Complutense de Madrid (UCM) & Instituto Ramón y Cajal de Investigaciones Sanitarias (IRYCIS). Plaza de Ramón y Cajal s/n, 28040 Madrid, Spain.

María Molina (M)

Departamento de Microbiología y Parasitología, Facultad de Farmacia, Universidad Complutense de Madrid (UCM) & Instituto Ramón y Cajal de Investigaciones Sanitarias (IRYCIS). Plaza de Ramón y Cajal s/n, 28040 Madrid, Spain.

Rafael Pulido (R)

Instituto de Investigación Sanitaria Biocruces Bizkaia, 48903 Barakaldo, Spain.
IKERBASQUE, Fundación Vasca para la Ciencia, 48011 Bilbao, Spain.

Víctor J Cid (VJ)

Departamento de Microbiología y Parasitología, Facultad de Farmacia, Universidad Complutense de Madrid (UCM) & Instituto Ramón y Cajal de Investigaciones Sanitarias (IRYCIS). Plaza de Ramón y Cajal s/n, 28040 Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH